Literature DB >> 27330499

Targeting the Preclinical Phase of Inflammatory Bowel Disease.

Jean-Frédéric Colombel1.   

Abstract

Year:  2015        PMID： 27330499      PMCID： PMC4849524     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.

Authors:  E Israeli; I Grotto; B Gilburd; R D Balicer; E Goldin; A Wiik; Y Shoenfeld
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

2.  Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.

Authors:  Lotte A van de Stadt; Margret H M T de Koning; Rob J van de Stadt; Gertjan Wolbink; Ben A C Dijkmans; Dörte Hamann; Dirkjan van Schaardenburg
Journal:  Arthritis Rheum       Date:  2011-11

3.  Serological markers predict inflammatory bowel disease years before the diagnosis.

Authors:  Fiona D M van Schaik; Bas Oldenburg; Andrew R Hart; Peter D Siersema; Stefan Lindgren; Olof Grip; Birgit Teucher; Rudolf Kaaks; Manuela M Bergmann; Heiner Boeing; Franck Carbonnel; Prevost Jantchou; Marie-Christine Boutron-Ruault; Anne Tjønneland; Anja Olsen; Francesca L Crowe; Petra H M Peeters; Martijn G H van Oijen; H Bas Bueno-de-Mesquita
Journal:  Gut       Date:  2012-07-26       Impact factor: 23.059

4.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

Authors:  Melissa R Arbuckle; Micah T McClain; Mark V Rubertone; R Hal Scofield; Gregory J Dennis; Judith A James; John B Harley
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

5.  Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

Authors:  J A James; X R Kim-Howard; B F Bruner; M K Jonsson; M T McClain; M R Arbuckle; C Walker; G J Dennis; J T Merrill; J B Harley
Journal:  Lupus       Date:  2007       Impact factor: 2.911

Review 6.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

7.  Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Authors:  Benjamin Pariente; Jean-Yves Mary; Silvio Danese; Yehuda Chowers; Peter De Cruz; Geert D'Haens; Edward V Loftus; Edouard Louis; Julian Panés; Jürgen Schölmerich; Stefan Schreiber; Maurizio Vecchi; Julien Branche; David Bruining; Gionata Fiorino; Matthias Herzog; Michael A Kamm; Amir Klein; Maïté Lewin; Paul Meunier; Ingrid Ordas; Ulrike Strauch; Gian-Eugenio Tontini; Anne-Marie Zagdanski; Cristiana Bonifacio; Jordi Rimola; Maria Nachury; Christophe Leroy; William Sandborn; Jean-Frédéric Colombel; Jacques Cosnes
Journal:  Gastroenterology       Date:  2014-09-21       Impact factor: 22.682
  7 in total
  3 in total

1.  Parabacteroides distasonis induces depressive-like behavior in a mouse model of Crohn's disease.

Authors:  Adrian Gomez-Nguyen; Abigail R Basson; Luc Dark-Fleury; Kristen Hsu; Abdullah Osme; Paola Menghini; Theresa T Pizarro; Fabio Cominelli
Journal:  Brain Behav Immun       Date:  2021-08-14       Impact factor: 19.227

2.  Chronic stress induces colonic tertiary lymphoid organ formation and protection against secondary injury through IL-23/IL-22 signaling.

Authors:  Adrian Gomez-Nguyen; Nikhilesh Gupta; Harsha Sanaka; Dennis Gruszka; Alaina Pizarro; Luca DiMartino; Abigail Basson; Paola Menghini; Abdullah Osme; Carlo DeSalvo; Theresa Pizarro; Fabio Cominelli
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

3.  The Level of Public Knowledge about Inflammatory Bowel Disease in Christchurch, New Zealand.

Authors:  Angharad Vernon-Roberts; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.